Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia

<b>Background.</b> The emergence, global spread, and persistence of SARS-CoV-2 resulted in an unprecedented need for effective antiviral drugs. Throughout the pandemic, various drug development and treatment strategies were adopted, including repurposing of antivirals designed for other viruses alon...

Description complète

Détails bibliographiques

Auteurs principaux:	Denise Siegrist, Hulda R. Jonsdottir, Mendy Bouveret, Bernadett Boda, Samuel Constant, Olivier B. Engler
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2024-09-01
Collection:	Pharmaceutics
Sujets:	SARS-CoV-2 antivirals molnupiravir nirmatrelvir GS-441524 ivermectin
Accès en ligne:	https://www.mdpi.com/1999-4923/16/10/1262
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!